Centene’s Shares Plunge After Withdrawing Guidance

Jul 03
Jul 03, 2025

Centene Corp. on July 1 withdrew its earnings guidance for the year, primarily citing struggles in the Affordable Care Act exchange segment. The company’s stock price declined by 40% in the day following the news and closed at $33.78 on July 2, its lowest price since March 2017.

Wells Fargo analysts in a July 1 note wrote that “exchange risk was already” factored into the stock price before the announcement, although they added that the “update is clearly incrementally negative.”
Read more
© 2025 MMIT

Tim Casey

Tim has been a reporter and editor for newspapers, websites and magazines for more than 20 years, including 10 years covering health care business topics. He has a deep knowledge of the managed care industry and pharmacy benefit management. He also has experience covering medical conferences and clinical and legislative health care issues. In 2014, the Society for Advancing Business Editing and Writing selected Tim as one of 15 journalists to participate in a national symposium on the Affordable Care Act. Tim has a B.A. in Psychology from the University of Notre Dame and an M.B.A. from Georgetown University.